NYSE ARCA | ETF
The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index.
The underlying index is composed of common stocks ofU. S. pharmaceutical companies.
These companies are engaged principally in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 5.27% |
| PFE | Pfizer Inc | Healthcare | Drug Manufacturers - General | 5.16% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 5.06% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 5.06% |
| BMY | Bristol-Myers Squibb Company | Healthcare | Drug Manufacturers - General | 5.02% |
| ABT | Abbott Laboratories | Healthcare | Medical Devices | 4.90% |
| JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 4.81% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 4.63% |
| PCRX | Pacira BioSciences, Inc. | Healthcare | Drug Manufacturers - Specialty & Generic | 4.04% |
| BHC | Bausch Health Companies Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.90% |
| TARO | Taro Pharmaceutical Industries Ltd | Healthcare | Drug Manufacturers - Specialty & Generic | 3.59% |
| TARS | Tarsus Pharmaceuticals Inc | Healthcare | Biotechnology | 3.07% |
| UTHR | United Therapeutics Corporation | Healthcare | Biotechnology | 2.87% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 2.86% |
| LQDA | Liquidia Technologies Inc | Healthcare | Biotechnology | 2.80% |
| COLL | Collegium Pharmaceutical Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 2.80% |
| SUPN | Supernus Pharmaceuticals Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 2.80% |
| LGND | Ligand Pharmaceuticals Incorporated | Healthcare | Biotechnology | 2.78% |
| OCUL | Ocular Therapeutix Inc | Healthcare | Biotechnology | 2.77% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 2.75% |